language_icon
EN
HI

Aptus Pharma Share price

APPL

360.5

4.50 (-1.23%)
Last updated on 23 Apr, 2026 | 15:15 IST
Today's High

360.50

Today's Low

360.50

52 Week Low

80.80

52 Week High

387.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aptus Pharma Chart

Aptus Pharma Share Key Metrics

Volume
2000.00
Market Cap
250.39 CR
LTQ@LTP
2000@360.50
ATP
360.5
Var Margin
100 %
Circuit Range
357.7-372.3
Delivery %
100 %
Value
7.21 L
ASM/GSM
No
Market Lot
2000

Summary

Aptus Pharma share price stands at ₹360.5 at 23 Apr, 2026 | 15:15. The stock Aptus Pharma intraday movement has stayed between ₹360.50 and ₹360.50, while on a 52-week basis it has fluctuated from ₹80.80 to ₹387.90.
In terms of trading activity, Aptus Pharma has recorded a volume of 2000 shares. The Aptus Pharma has a market cap of ₹6860000. The stock’s Average Traded Price (ATP) stands at ₹36050, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2000, 36050.
The Aptus Pharma operates within a circuit range of ₹357.7-372.3 – ₹357.7-372.3, with a Value of ₹7.21 L. The Delivery Percentage for the day is 100%. Additionally, Aptus Pharma currently falls under the No framework, and trades with a market lot size of 2000.

Aptus Pharma Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

42.36

Sector P/B

2.11

Sec. Div. Yield

80.52

Aptus Pharma Resistance and Support

Pivot 364.87

Resistance

First Resistance

365.14

Second Resistance

365.27

Third Resistance

365.54

Support

First Support

364.74

Second Support

364.47

Third Support

364.34

Aptus Pharma Shareholding Pattern

View More
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

72.89%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

27.11%

Others

0%

Total Promoters
MAR '26
72.89%

Aptus Pharma Corporate Actions

DateAgenda
2026-04-27Audited Results
2026-03-24Bonus issue & Others
2025-11-10Half Yearly Results

Aptus Pharma News

Aptus Pharma Ltd - 544529 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Aptus Pharma is set to issue bonus shares in a 3:2 ratio and increase its authorized share capital to ₹25 crores. Shareholder e-voting for these resolutions will take place from March 27 to April 25, 2026.
Mar 26 2026 19:03:00

Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On March 24, 2026

Aptus Pharma board recommended a 3:2 bonus share issue and approved an increase in authorized share capital from ₹7.15 crores to ₹25 crores. Both proposals are subject to approval by the company's members through a postal ballot.
Mar 24 2026 19:03:00

About Aptus Pharma

NSE : 0  
BSE : 544529  
ISIN : INE15XJ01010  

Our Company was originally incorporated as “Aptus Pharma Private Limited” as a private limited company under the provisions of the Companies Act 1956 pursuant to a Certificate of Incorporation dated August 12 2010 issued by the Registrar of Companies Gujarat. Subsequently our Company was converted into a public limited company in accordance with the provisions of the Companies Act 2013 pursuant to a special resolution passed by the shareholders in their extraordinary general meeting held on November 30 2024. A fresh Certificate of Incorporation consequent upon such conversion was issued by the Registrar of Companies Central Processing Centre on December 12 2024 and the name of our Company was changed to “Aptus Pharma Limited.” The Corporate Identification Number of our Company is U24230GJ2010PLC061957.MAJOR EVENTS:2010- Incorporation of our company under the name “Aptus Pharma Private Limited”2011-2013- Commenced operations through four regional headquarters in Gujarat. Launched a portfolio of 25 products targeting essential therapeutic segments.2013–2016- Achieved approximately 33% geographical coverage in Gujarat. Expanded product portfolio to over 50 products catering to both acute and chronic segments.2016–2019- Increased portfolio to over 70 products in response to evolving therapeutic requirements.2019–2022- Extended presence to around 80% of Gujarat including remote areas. Product portfolio grew to over 100 products. Appointed a C&F agent in Ahmedabad and improved logistics infrastructure.2022-2024- Achieved full geographical coverage across Gujarat. Expanded product portfolio to over 175 products. Established three operational divisions: Acute Chronic and OTC. Initiated in-house manufacturing under a loan license arrangement.2024- Converted to a public limited company and changed name to “Aptus Pharma Limited”.

Read More

Aptus Pharma Management

NamePosition
Tejash Maheshchandra HathiManaging Director
Chetan Shantilal LalsetaNon Executive Director
View More

Aptus Pharma Similar Stocks

No Data Found

Aptus Pharma FAQs

The Buying Price of Aptus Pharma share is 360.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Aptus Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aptus Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Aptus Pharma shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Aptus Pharma shares is 0. Useful to assess the stock's value relative to its book value.

To assess Aptus Pharma’s valuation compare Sector P/E, P/B which are 42.36 & 2.11 with sector averages, along with growth rates and financial metrics.

The Market Cap of Aptus Pharma is 250.39 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Aptus Pharma share price is 387.90 & 80.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Aptus Pharma belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost